{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:43:39Z","timestamp":1792557819123,"version":"4.5.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Tuberc."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>University students, particularly those from tuberculosis (TB)-endemic countries and students in health professions, are at increased risk for latent tuberculosis infection (LTBI). In the United States (U.S.), TB screening is required for applicants for permanent residency and refugee status but not for individuals entering on student visas, and institutional policies vary. At our university, which requires pre-matriculation TB screening for all incoming students, low LTBI treatment completion rates prompted a review of care delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective chart review of students diagnosed with LTBI at a medium-sized private university from 2018 to 2023. Records identified by ICD-10 codes were reviewed for demographics, school enrollment, testing method, regimen, and treatment outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 687 students with TB-related visits, 82 (12%) were diagnosed with LTBI. Median age was 27 years (interquartile range 23\u201331); 55% were female and 65% were non-U.S.-born, most often from China and India. Students represented nine schools, with Medicine (17%) and Nursing (14%) comprising about one-third of cases. Forty-eight students (59%) initiated treatment, while 34 (41%) did not, primarily due to declining therapy or incomplete follow-up. Among those treated, 22 (46%) completed therapy, corresponding to 27% overall. Completion was highest for nine months of isoniazid (88%) and lowest for 4 months of rifampin (17%). Several documentation and follow-up gaps were identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Losses across the LTBI care cascade were common in this university setting and reflect patterns reported in other U.S. and international studies. Strengthening education, follow-up, access to shorter regimens, and documentation may improve completion rates and support TB elimination goals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/ftubr.2025.1710215","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:47:51Z","timestamp":1762429671000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Low treatment completion rates reveal gaps in the LTBI care cascade among university students"],"prefix":"10.3389","volume":"3","author":[{"given":"Anu K.","family":"Murthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda A.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"B1","unstructured":"Geneva, Switzerland\n          World Health Organization\n          Latent Tuberculosis Infection: Updated and Consolidated Guidelines for Programmatic Management\n          \n          2018"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med."},{"key":"B3","unstructured":"Geneva, Switzerland\n          World Health Organization\n          The End TB Strategy\n          \n          2015"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.3201\/eid2410.180716","article-title":"Simple estimates for local prevalence of latent tuberculosis infection, United States, 2011\u20132015","volume":"24","author":"Haddad","year":"2018","journal-title":"Emerg Infect Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0249012","DOI":"10.1371\/journal.pone.0249012","article-title":"State-level prevalence estimates of latent tuberculosis infection in the United States by medical risk factors, demographic characteristics and nativity","volume":"16","author":"Mirzazadeh","year":"2021","journal-title":"PLoS ONE."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e2221186120","DOI":"10.1073\/pnas.2221186120","article-title":"Reevaluating progression and pathways following Mycobacterium tuberculosis infection within the spectrum of tuberculosis","volume":"120","author":"Horton","year":"2023","journal-title":"Proc Natl Acad Sci USA."},{"key":"B7","unstructured":"Atlanta, GA\n          US Department of Health and Human Services, CDC\n          Reported Tuberculosis in the United States, 2023\n          \n          2024"},{"key":"B8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1136\/thoraxjnl-2015-207915","article-title":"Mind the gap: TB trends in the USA and the UK, 2000\u20132011","volume":"71","author":"Nnadi","year":"2016","journal-title":"Thorax."},{"key":"B9","unstructured":"Atlanta, GA\n          US Department of Health and Human Services, CDC\n          Reported tuberculosis in the United States, 2023\n          \n          2024"},{"key":"B10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12916-016-0595-5","article-title":"The impact of migration on tuberculosis epidemiology and control in high-income countries: a review","volume":"14","author":"Pareek","year":"2016","journal-title":"BMC Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s41256-025-00424-y","article-title":"Prevalence of tuberculosis among migrants under national screening programs: a systematic review and meta-analysis","volume":"10","author":"Chen","year":"2025","journal-title":"Glob Health Res Policy."},{"key":"B12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/07448481.2017.1363765","article-title":"Toward a generation free of tuberculosis: TB disease and infection in individuals of college age in the United States","volume":"66","author":"Shah","year":"2018","journal-title":"J Am Coll Health."},{"key":"B13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/07448481.2015.1117465","article-title":"US college and university student health screening requirements for tuberculosis and vaccine-preventable diseases, 2012","volume":"64","author":"Jewett","year":"2016","journal-title":"J Am Coll Health."},{"key":"B14","unstructured":"Silver Spring, MD\n          ACHA\n          Tuberculosis (TB) Risk Assessment and Management\n          \n          2025"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6901a1","article-title":"Guidelines for the treatment of latent tuberculosis infection: recommendations from the National Tuberculosis Controllers Association and CDC, 2020","volume":"69","author":"Sterling","year":"2020","journal-title":"MMWR Recomm Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","article-title":"The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis","volume":"16","author":"Alsdurf","year":"2016","journal-title":"Lancet Infect Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1513\/AnnalsATS.201508-547OC","article-title":"High rates of tuberculosis and opportunities for prevention among international students in the United States","volume":"13","author":"Collins","year":"2016","journal-title":"Ann Am Thorac Soc."},{"key":"B18","article-title":"WHO Consolidated Guidelines on Tuberculosis","volume-title":"Module 2: Screening \u2013 Systematic Screening for Tuberculosis Disease","year":"2021"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.5588\/ijtld.18.0035","article-title":"Improved treatment completion with shorter treatment regimens for latent tuberculous infection","volume":"22","author":"Macaraig","year":"2018","journal-title":"Int J Tuberc Lung Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12879-017-2245-8","article-title":"Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine","volume":"17","author":"McClintock","year":"2017","journal-title":"BMC Infect Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"689","DOI":"10.7326\/M17-1150","article-title":"Self-administered versus directly observed once-weekly isoniazid and rifapentine treatment of latent tuberculosis infection: a randomized trial","volume":"167","author":"Belknap","year":"2017","journal-title":"Ann Intern Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12879-017-2377-x","article-title":"Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses","volume":"17","author":"Pease","year":"2017","journal-title":"BMC Infect Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"E151","DOI":"10.1097\/PHH.0000000000001077","article-title":"Factors associated with latent tuberculosis infection treatment failure among patients with commercial health insurance\u2014United States, 2005\u20132016","volume":"27","author":"Iqbal","year":"2021","journal-title":"J Public Health Manag Pract."},{"key":"B25","doi-asserted-by":"publisher","first-page":"E25","DOI":"10.1097\/PHH.0000000000000628","article-title":"Tuberculosis prevention in the private sector: using claims-based methods to identify and evaluate latent tuberculosis infection treatment with isoniazid among the commercially insured","volume":"24","author":"Stockbridge","year":"2018","journal-title":"J Public Health Manag Pract."},{"key":"B26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/PHH.0000000000001711","article-title":"Patient-reported barriers to treatment initiation and completion for latent tuberculosis infection among patients within a large integrated health care system in Southern California","volume":"29","author":"Spence","year":"2023","journal-title":"J Public Health Manag Pract."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1587839","DOI":"10.3389\/ftubr.2025.1587839","article-title":"Assessment of knowledge, attitudes, and practices regarding TB prevention and treatment among college students in Wuhan, central China","volume":"3","author":"Wu","year":"2025","journal-title":"Front Tuberc."},{"key":"B28","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3122\/jabfm.2017.04.170070","article-title":"Factors that influence treatment completion for latent tuberculosis infection","volume":"30","author":"Eastment","year":"2017","journal-title":"J Am Board Fam Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1001\/jama.2023.4899","article-title":"Screening for latent tuberculosis infection in adults: US Preventive Services Task Force recommendation statement","volume":"329","author":"US","year":"2023","journal-title":"JAMA"},{"key":"B30","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3201\/eid2803.212131","article-title":"Overseas treatment of latent tuberculosis infection in U. S-bound immigrants","volume":"28","author":"Khan","year":"2022","journal-title":"Emerg Infect Dis."}],"container-title":["Frontiers in Tuberculosis"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftubr.2025.1710215\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T11:47:54Z","timestamp":1762429674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftubr.2025.1710215\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":30,"alternative-id":["10.3389\/ftubr.2025.1710215"],"URL":"https:\/\/doi.org\/10.3389\/ftubr.2025.1710215","relation":{},"ISSN":["2813-7868"],"issn-type":[{"value":"2813-7868","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"article-number":"1710215"}}